China Endeavor Registry: A Registry With The Endeavor Zotarolimus Eluting Coronary Stent in China
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bo Xu, Director
Fu Wai Hospital, Beijing, China
Principal Investigator - Jiyan Chen, Professor
Guangdong Provincial People's Hospital
Principal Investigator - Weimin Wang, Professor
Beijing People's Hospital
Principal Investigator - Yaling Han, Professor
Shenyang North Hospital
Principal Investigator - Yong Huo, Professor
Peking University First Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2007
- Primary completion
- 30 Sept 2009
- Completion
- 30 Sept 2010
- Last update posted
- 17 Oct 2012
- Registered enrollment
- 2,210
- Registry id
- NCT00793312
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.